With a late-stage trial win for its Norditropin heir in hand, Novo Nordisk is making good on plans to boost its profile in the realm of rare disease. Over the weekend, Novo unveiled data from the ...

Rare growth disorders are a diverse group of uncommon conditions that affect an individual’s physical development. They may stem from genetic mutations, hormonal imbalances, or other complex factors.

Growth disorders are conditions that cause faster or slower growth than usual. People with these disorders may have unusually sized limbs and body parts or may be taller or shorter than expected.